Arovella Therapeutics Ltd is pleased to be listed as one of the “ASX biotech winners for September”.
The Australian: ASX biotech September winners: Healthcare down 5pc, but experts say it’s still best sector in a recession
Previous
Previous
Arovella licenses novel solid tumour targeting technology
Next
Next